Nasus Pharma Prices $10 Million Initial Public Offering-February 2024-www.financetom.com

Nasus Pharma Prices $10 Million Initial Public Offering

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Nasus Pharma Prices $10 Million Initial Public Offering

Aug 13, 2025 5:12 AM

07:53 AM EDT, 08/13/2025 (MT Newswires) -- Nasus Pharma ( NSRX ) said Wednesday it priced its initial public offering of 1.25 million shares at $8 each, for gross proceeds of $10 million.

The clinical-stage pharmaceutical company said IPO underwriters have a 45-day overallotment option to purchase up to 187,500 additional shares.

The company expects its shares to start trading on the New York Stock Exchange under the ticker symbol "NSRX" on Wednesday, while the IPO is expected to close Thursday.

Previous page： Zee moves Bombay High Court to declare Invesco requisition notice ‘illegal, invalid’ Next page： Work from home to end soon. Here's how IT firms are planning to return to office

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Zee moves Bombay High Court to declare Invesco requisition notice ‘illegal, invalid’

Oct 2, 2021

Zee Entertainment Enterprises Limited has filed a suit before the Bombay High Court requesting it to declare shareholders Invesco Developing Markets Fund and OFI Global China Fund LLC’s requisition notice to hold an extraordinary meeting (EGM) illegal and invalid.

Work from home to end soon. Here's how IT firms are planning to return to office

Oct 3, 2021

The corporations across the world are gearing up to call back their employees to office.

BOTTOMLINE: Zee’s real unanswered questions

Oct 2, 2021

The most important question today is not whether Invesco (Oppenheimer) has the right to call an EGM and recast the board, which the courts will decide. The most important question is: Has Punit Goenka lost the right to continue?

NCLT to hear Zee-Invesco case today: Experts believe Bombay HC unlikely to consider suit

Oct 4, 2021

Days after the National Company Law Tribunal (NCLT) asked Zee's board to consider Invesco Developing Markets Fund and OFI Global China Fund LLC’s request for an Extraordinary General Meeting (EGM), Zee Entertainment Enterprises Limited (ZEEL) filed a suit before the Bombay High Court requesting it to declare shareholders Invesco Developing Markets Fund and OFI Global China Fund LLC’s requisition to hold an extraordinary meeting (EGM) illegal and invalid, the company said on Saturday. HP Ranina, economist, corporate lawyer, Hetal Dalal, president and COO, IiAS, and JN Gupta, former ED, Securities and Exchange Board of India and managing director at Stakeholders Empowerment Services, discussed this further.